AlexandraGomez ArteagaMD

Hematologic Oncology

Assistant Professor of Medicine/Bone Marrow Transplant & Cell Therapy Program

Overview of Dr. Gomez Arteaga

Dr. Alexandra Gomez Arteaga is an oncologist in New York, NY and is affiliated with New York-Presbyterian Hospital. She specializes in hematologic oncology and is experienced in bone marrow transplantation, acute myeloid leukemia, multiple myeloma, lymphoma, and myelodysplastic syndromes .

Office
520 E 70th St
# F364
New York, NY 10021
Book by Phone+1(774) 295-5541

Fax+1 212-746-6678

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Blood & Bone Marrow Transplant, 2019 - 2020
New York Presbyterian HospitalFellowship, Hematology and Medical Oncology, 2016 - 2019
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2013 - 2016
Universidad de los AndesClass of 2011

Certifications & Licensure

NY State Medical License 2016 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia Start of enrollment: 2015 Sep 10
Terminated
Phase 2
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

18 citations
Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation.
Alexandra Gomez-Arteaga, Elizabeth Margolskee, Mike Wei, Koen van Besien, Giorgio Inghirami
Leukemia & Lymphoma. 2019-04-18
7 citations
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.
Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei-Jie Zhang, Khalid Bo-Subait
Blood Advances. 2021-09-22
7 citations
Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma.
Peter J. Hosein, Jose D. Sandoval-Sus, Deborah Goodman, Alexandra Gomez Arteaga, Isildinha M. Reis
American Journal of Hematology. 2015-06-01

Abstracts/Posters

Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration
Alexandra Gomez-Arteaga, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Other Languages

French, Spanish